Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.

Hajira Dambha-Miller William Hinton Christopher R Wilcox Mark P Joy Michael D Feher Simon de Lusignan

Published in: Family practice (2022)

We found that HRT prescription within 6 months of a recorded diagnosis of COVID-19 infection was associated with a reduction in all-cause mortality. Further work is needed in larger cohorts to examine the association of COCP in COVID-19, and to further investigate the hypothesis that oestrogens may contribute a protective effect against COVID-19 severity.

Keyphrases

coronavirus disease
sars cov
replacement therapy
respiratory syndrome coronavirus
smoking cessation
cardiovascular events
cardiovascular disease
risk factors
adipose tissue